The company was founded in 1999. It was formerly known as Vertis Neuroscience, Inc. and changed its name to Northstar Neuroscience, Inc. in 2003. Northstar Neuroscience is headquartered in Seattle, Washington. With 25.88 million shares outstanding and 3.83 million shares declared short as of January 2008, there is a failure to deliver in shares of NSTR. According to quarterly data provided by the SEC, there were still 10,641 shares of NSTR that were failing-to-deliver as of September 4, 2007.